You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 24, December 24/31, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Viral Infections
 •World Health
 •Pulmonary Diseases, Other
 •Alert me on articles by topic

The SARS Response—Building and Assessing an Evidence-Based Approach to Future Global Microbial Threats

James M. Hughes, MD

JAMA. 2003;290:3251-3253.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

On February 21, 2003, an ill physician traveling from China's Guangdong Province spent 1 night on the ninth floor of a Hong Kong hotel. During the next 24 hours, this individual would infect more than a dozen other hotel guests and visitors.1 Within days, these guests would transmit their infections to health care workers and family members in Hong Kong, Vietnam, Singapore, and Canada, providing a vivid illustration of the rapidity and ease with which infectious diseases can spread and marking the start of the global outbreak of severe acute respiratory syndrome (SARS). One of the first persons to recognize the potential gravity of the situation was Carlo Urbani, an infectious disease physician working for the World Health Organization (WHO) in Hanoi. Urbani observed that a patient who had recently arrived from Hong Kong had a highly transmissible form of atypical pneumonia, and he promptly alerted . . . [Full Text of this Article]

Author Affiliation: National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Future of Diabetes: What Is There Besides New Medicines?
Vinicor
Clin. Diabetes 2004;22:94-96.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.